PAB Share Price |
||||
| Open | 0.02 | Change | Price | % |
| High | 0.02 | 1 Day | 0.00 | 0.00 |
| Low | 0.02 | 1 Week | 0.00 | 0.00 |
| Close | 0.02 | 1 Month | 0.00 | 0.00 |
| Volume | 5263647 | 1 Year | 0.01 | 100.00 |
| 52 Week High 0.03 | ||||
| 52 Week Low 0.00 | ||||
| PAB Important Levels | |
| Resistance 2 | 0.02 |
| Resistance 1 | 0.02 |
| Pivot | 0.02 |
| Support 1 | 0.02 |
| Support 2 | 0.02 |
| ASX Australia Most Active Stocks | |||
| COE | 0.30 | 3.45% | |
| COE | 0.30 | 3.45% | |
| GPP | 0.02 | 0.00% | |
| DUE | 3.02 | 1.00% | |
| DUE | 3.02 | 1.00% | |
| BUR | 0.02 | 0.00% | |
| BUR | 0.02 | 0.00% | |
| BUR | 0.02 | 0.00% | |
| AGO | 0.02 | 0.00% | |
| AGO | 0.02 | 0.00% | |
| ASX Australia Top Gainers Stocks | |||
| KSO | 0.40 | 3900.00% | |
| XST | 0.02 | 100.00% | |
| XST | 0.02 | 100.00% | |
| ATP | 0.03 | 50.00% | |
| ATP | 0.03 | 50.00% | |
| PMQ | 0.03 | 50.00% | |
| RMI | 0.03 | 50.00% | |
| RMI | 0.03 | 50.00% | |
| BNV | 0.03 | 50.00% | |
| IRM | 0.03 | 50.00% | |
| ASX Australia Top Losers Stocks | |||
| APP | 0.20 | -80.00% | |
| APP | 0.20 | -80.00% | |
| APP | 0.20 | -80.00% | |
| APP | 0.20 | -80.00% | |
| TCQ | 0.27 | -73.53% | |
| EMG | 0.01 | -50.00% | |
| EMG | 0.01 | -50.00% | |
| EMG | 0.01 | -50.00% | |
| EMG | 0.01 | -50.00% | |
| GDY | 0.01 | -50.00% | |
Patrys Ltd (ASX: PAB)
| PAB Technical Analysis | 3 |
| As on 1st Nov 2017 PAB Share Price closed @ 0.02 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.01 & Buy for SHORT-TERM with Stoploss of 0.01 we also expect STOCK to react on Following IMPORTANT LEVELS. | |
| PAB Target for April | |
| 1st Target up-side | 0.03 |
| 2nd Target up-side | 0.03 |
| 3rd Target up-side | 0.03 |
| 1st Target down-side | 0.01 |
| 2nd Target down-side | 0.01 |
| 3rd Target down-side | 0.01 |
Patrys Ltd ( ASX Australia Symbol : PAB ) Sector : Healthcare And Other Stocks in Same Sector |
|||||
|
EMG
0.01 -0.01 (-50.00 %) LT : Strong Sell ST : Strong Sell |
SYR
3.38 0.01 (0.30 %) LT : Buy ST : Buy |
SRI
0.01 0.00 (0.00 %) LT : Strong Sell ST : Strong Sell |
SBM
2.99 0.09 (3.10 %) LT : Strong Buy ST : Strong Buy |
TNG
0.16 0.02 (14.29 %) LT : Buy ST : Strong Buy |
|
|
|
||||||||||||||||||||||
|
Interactive Technical Analysis Chart Patrys Ltd ( PAB ASX Australia )
Your Comments and Response on Patrys Ltd
PAB Business Profile
Patrys Limited, a clinical stage biotechnology company, together with its subsidiaries, develops natural human antibodies as therapies for cancer and other major diseases in Australia. The companys clinical products include PAT-SM6, a natural human antibody used for the treatment of multiple types of cancer, including solid tumors, such as melanoma, breast, colon, and pancreatic, as well as blood-based cancers that include multiple myeloma; and PAT-SC1 for treating gastric cancer and solid tumors. It also has late stage preclinical products, such as PAT-LM1, a natural human antibody that is used in the treatment for multiple types of cancer against colon, lung, breast, ovary, and pancreatic cancers. The company was founded in 2006 and is headquartered in Melbourne, Australia.